Low-Dose Lithium Eases Mild Cognitive Impairment

JAMA Network

About The Study: This pilot randomized clinical trial established feasibility, confirmed safety and tolerability, and generated effect size estimates for future trials of low-dose lithium in mild cognitive impairment. None of the coprimary outcomes met the prespecified significance threshold.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.